Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 2

Status

Unknown 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Solid Tumor 2

Interventions

Cisplatin 3193Cyclophosphamide 3187Carboplatin 2968Radiotherapy 2784Paclitaxel 2716Gemcitabine 2569pembrolizumab 2378Bevacizumab 2206Docetaxel 2196Fluorouracil 1848Capecitabine 1828Oxaliplatin 1738Dexamethasone 1604Nivolumab 1580Doxorubicin 1501Rituximab 1487Magnetic Resonance Spectroscopy 1382Etoposide 1345Irinotecan 1245Leucovorin 1222Drug Therapy 1202Cytarabine 1130Pemetrexed 1074fludarabine 1056Specimen Handling 1009Vincristine 964Cetuximab 943Prednisone 940Trastuzumab 940Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
alpha-Synuclein × Clear all
NCT03815084 2019-01-30

A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
100 enrolled
Other solid neoplasm

Solid Tumor

NCT03815630 2019-01-30

DC-CIK

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
100 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡